Estrogen mediated expression of nucleophosmin 1 in human endometrial carcinoma clinical stages through estrogen receptor-α signaling

Cancer Cell International

Volumn 14, Issue 1, 2014, Pages

  Zhou, Yunxiao ^a   Shen, Jie ^a   Xia, Liqun ^a   Wang, Yanli ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Endometrial carcinomas; Estrogen; Estrogen receptor (ER ); Nucleophosmin 1(NPM1)

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NUCLEOPHOSMIN;

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATIONAL STUDY; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIDDLE AGED; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

EID: 84924098794     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/s12935-014-0145-1     Document Type: Article

References (38)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
2. Wong Y, Cheung T, Lo K, Yim S, Siu N, Chan S, Ho T, Wong K, Yu M, Wang V: Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling. Oncogene 2006, 26:1971-1982.
3. Zhang Y, Liu Z, Yu X, Zhang X, Lü S, Chen X, Lü B: The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol Oncol 2010, 117:41-46.
4. Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983, 15:10-17.
5. Yung BY, Busch H, Chan PK: Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis. Biochim Biophys Acta 1985, 826:167-173.
6. Feuerstein N, Mond JJ: "Numatrin," a nuclear matrix protein associated with induction of proliferation in B lymphocytes. J Biol Chem 1987, 262:11389-11397.
7. Schmidt-Zachmann MS, Hugle-Dorr B, Franke WW: A constitutive nucleolar protein identified as a member of the nucleoplasmin family. EMBO J 1987, 6:1881-1890.
8. Kang Y-J, Olson MO, Busch H: Phosphorylation of acid-soluble proteins in isolated nucleoli of Novikoff hepatoma ascites cells. Effects of divalent cations. J Biol Chem 1974, 249:5580-5585.
9. Kang Y-J, Olson MO, Jones C, Busch H: Nucleolar phosphoproteins of normal rat liver and Novikoff hepatoma ascites cells. Cancer Res 1975, 35:1470-1475.
10. Borer R, Lehner C, Eppenberger H, Nigg E: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989, 56:379-390.
11. Okuwaki M, Tsujimoto M, Nagata K: The RNA binding activity of a ribosome biogenesis factor, nucleophosmin/B23, is modulated by phosphorylation with a cell cycle-dependent kinase and by association with its subtype. Mol Biol Cell 2002, 13:2016-2030.
12. Okuda M: The role of nucleophosmin in centrosome duplication. Oncogene 2002, 21:6170-6174.
13. Tarapore P, Okuda M, Fukasawa K: A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and nucleophosmin/B23 in centrosome duplication. Cell Cycle 2002, 1:75-81.
14. Chan P, Aldrich M, Busch H: Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation. Exp Cell Res 1985, 161:101-110.
15. Kurki S, Peltonen K, Laiho M: Nucleophosmin, HDM2 and p53: players in UV damage incited nucleolar stress response. Cell Cycle 2004, 3:976-979.
16. Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K, Pandolfi PP: Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005, 437:147-153.
17. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, La Starza R, Diverio D, Colombo E, Santucci A: Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005, 352:254-266.
18. Gimenez M, de Oliveira Souza VC, Izumi C, Barbieri MR, Chammas R, Oba-Shinjo SM, Uno M, Marie SKN, Rosa JC: Proteomic analysis of low-to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin. Proteomics 2010, 10:2812-2821.
19. Nozawa Y, Van Belzen N, Van Der M, Dinjens WN, Bosman FT: Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J Pathol 1996, 178:48-52.
20. Yun J, Miao J, Chen G, Tian Q, Zhang C, Xiang J, Fu J, Lai P: Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. Br J Cancer 2007, 96:477-484.
21. Tsui K-H, Cheng A-J, Pan T-L, Yung BY-M: Association of nucleophosmin/B23 mRNA expression with clinical outcome in patients with bladder carcinoma. Urology 2004, 64:839-844.
22. Skaar TC, Prasad SC, Sharareh S, Lippman ME, Brünner N, Clarke R: Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells. J Steroid Biochem Mol Biol 1998, 67:391-402.
23. Shields LB, Gerçel-Taylor Ç, Yashar CM, Wan TC, Katsanis WA, Spinnato JA, Taylor DD: Induction of immune responses to ovarian tumor antigens by multiparity. J Soc Gynecol Investig 1997, 4:298-304.
24. Subong EN, Shue MJ, Epstein JI, Briggman JV, Chan PK, Partin AW: Monoclonal antibody to prostate cancer nuclear matrix protein (PRO: 4-216) recognizes nucleophosmin/B23. Prostate 1999, 39:298-304.
25. Grisendi S, Mecucci C, Falini B, Pandolfi PP: Nucleophosmin and cancer. Nat Rev Cancer 2006, 6:493-505.
26. Chao A, Lin C-Y, Tsai C-L, Hsueh S, Lin Y-Y, Lin C-T, Chou H-H, Wang T-H, Lai C-H, Wang H-S: Estrogen stimulates the proliferation of human endometrial cancer cells by stabilizing nucleophosmin/B23 (NPM/B23). J Mol Med 2013, 91:249-259.
27. Karhemo P-R, Rivinoja A, Lundin J, Hyvönen M, Chernenko A, Lammi J, Sihto H, Lundin M, Heikkilä P, Joensuu H: An extensive tumor array analysis supports tumor suppressive role for nucleophosmin in breast cancer. Am J Pathol 2011, 179:1004-1014.
28. Tanaka M, Sasaki H, Kino I, Sugimura T, Terada M: Genes preferentially expressed in embryo stomach are predominantly expressed in gastric cancer. Cancer Res 1992, 52:3372-3377.
29. Feuerstein N, Spiegel S, Mond JJ: The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody. J Cell Biol 1988, 107:1629-1642.
30. Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease LA, Chan PK: Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 1989, 28:1033-1039.
31. Sivridis E, Giatromanolaki A: The pathogenesis of endometrial carcinomas at menopause: facts and figures. J Clin Pathol 2011, 64:553-560.
32. Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, Peeters PH, Onland-Moret NC, Lahmann PH, Berrino F: Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2008, 15:485-497.
33. Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C: Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 2004, 108:425-432.
34. Zeleniuch-Jacquotte A, Akhmedkhanov A, Kato I, Koenig KL, Shore RE, Kim MY, Levitz M, Mittal KR, Raju U, Banerjee S, Toniolo P: Postmenopausal endogenous oestrogens and risk of endometrial cancer: results of a prospective study. Br J Cancer 2001, 84:975-981.
35. Lepine J, Audet-Walsh E, Gregoire J, Tetu B, Plante M, Menard V, Ayotte P, Brisson J, Caron P, Villeneuve L, Bélanger A, Guillemette C: Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways. J Clin Endocrinol Metabol 2010, 95:2689-2698.
36. Lim MJ, Wang XW: Nucleophosmin and human cancer. Cancer Detect Prev 2006, 30:481-490.
37. Kato S, Espinoza N, Lange S, Villalón M, Cuello M, Owen GI: Characterization and phenotypic variation with passage number of cultured human endometrial adenocarcinoma cells. Tissue Cell 2008, 40:95-102.
38. Smith HO, Stephens ND, Qualls CR, Fligelman T, Wang T, Lin C-Y, Burton E, Griffith JK, Pollard JW: The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol 2013, 7:41-54.